RCKT 13D/13G Filings - ROCKET PHARMACEUTICALS INC.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares have beem adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2022-02-10 08:37 am Purchase	2021-12-31	13G	Rocket Pharmaceuticals, Inc. RCKT	The Vanguard Group	3,301,138 5.120%	3,301,138 (New Position)	Filing History
2022-02-04 4:12 pm Purchase	2021-12-31	13G	Rocket Pharmaceuticals, Inc. RCKT	BLACKROCK INC BLK	3,339,469 5.200%	3,339,469 (New Position)	Filing History
2022-02-04 09:22 am Purchase	2021-12-31	13G	Rocket Pharmaceuticals, Inc. RCKT	WELLINGTON MANAGEMENT CO LLP	3,490,879 5.420%	3,490,879 (New Position)	Filing History
2021-08-31 5:08 pm Purchase	2021-05-11	13D	Rocket Pharmaceuticals, Inc. RCKT	RTW Investments, LP	16,272,635 25.300%	87,516 (+0.54%)	Filing History
2021-03-29 5:19 pm Sale	2021-03-24	13D	Rocket Pharmaceuticals, Inc. RCKT	RTW Investments, LP	16,185,119 26.200%	-1,344,925 (-7.67%)	Filing History
2021-02-16 3:45 pm Purchase	2020-12-31	13G	Rocket Pharmaceuticals, Inc. RCKT	PERCEPTIVE ADVISORS LLC	3,396,867 5.600%	3,396,867 (New Position)	Filing History
2021-02-16 12:23 pm Purchase	2020-12-31	13G	Rocket Pharmaceuticals, Inc. RCKT	PRICE T ROWE ASSOCIATES INC	3,479,321 5.700%	3,479,321 (New Position)	Filing History
2021-01-08 3:30 pm Purchase	2020-12-10	13D	Rocket Pharmaceuticals, Inc. RCKT	RTW Investments, LP	17,530,044 29.300%	247,720 (+1.43%)	Filing History

Goto Prev, 0, 1